R. Audran

Discipline

Histoire, Philosophie et Sociologie des sciences (1)

Type de document

Articles (7)

Co-auteur

Date

Source

Mot-clé

procès (6) Methods (5) Methods (5) Volunteers (4) Cells (4) Adulthood (4) anticorps (3) Vaccines (3) Mice (3) Human beings (3) Immunoglobulins (3) Blood (3) Antigens (3) Older people (3) Addition (3) Number (3) puits (2) test (2) sécurité (2) enregistrement (2) pollen (2) paludisme (2) allergène (2) effet (2) dose (2) comparaison (2) adulte (2) abords (agglomération) (2) Lausanne (2) Development (2)

Documents écrit par R. Audran (7) | parle de R. Audran (0)

The adjuvant GLA-SE promotes human Tfh cell expansion and emergence of public TCRβ clonotypes.
D.L. Hill et al. (5 août 2019)
Reactogenicity to major tuberculosis antigens absent in BCG is linked to improved protection against Mycobacterium tuberculosis.
N. Aguilo et al. (14 juil. 2017)
Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study.
O. De Santis et al. (2016)
Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial.
F. Spertini et al. (2015)
Comparison of two oral probiotic preparations in a randomized crossover trial highlights a potentially beneficial effect of Lactobacillus paracasei NCC2461 in patients with allergic rhinitis.
Y. Perrin et al. (2014)
Novel birch pollen specific immunotherapy formulation based on contiguous overlapping peptides.
C. Pellaton et al. (2013)
A malaria vaccine that elicits in humans antibodies able to kill Plasmodium falciparum.
P. Druilhe et al. (2005)